Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries
Early Phase 1
Withdrawn
- Conditions
- Catheter-Associated Urinary Tract Infection, Ascorbic Acid
- Interventions
- Drug: Ascorbic Acid 1000 MG
- Registration Number
- NCT03800667
- Lead Sponsor
- American University of Beirut Medical Center
- Brief Summary
This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Non pregnant women at least 18 years of age visiting the Preadmission unit (PAU) or the OBGYN floor (7N), presenting for elective GYN surgery at the American University of Beirut Medical Center (AUBMC).
Read More
Exclusion Criteria
-
Any women with the following:
- Nephrolithiasis
- Congenital anomaly or neurogenic bladder
- Allergy to ascorbic acid
- Who require therapeutic anticoagulant medicine during the 6 weeks after surgery
- Surgery did involve a fistula repair or a vaginal mesh removal
- Positive Urinalysis in the PAU
- Recurrent UTI's
- Diabetes
- G6PD
- Hemochromatosis
- Renal disorders
Patients already taking Vitamin C supplementation will also be excluded from the study.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Women on a vitamin C regimen Ascorbic Acid 1000 MG Women who are undergoing elective gynecological surgeries and who are randomized to take 1000 mg of vitamin C for one month,
- Primary Outcome Measures
Name Time Method Proportion of participants who experienced clinically diagnosed and treated UTI. 30 days Urinary tract infection is diagnosed by a positive urine culture.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
American University of Beirut Medical Center
🇱🇧Beirut, Lebanon